12.18.25 -- Balancing GLP-1 Quality With Demand

Discover how continuous manufacturing, AI-driven digital twins, and advanced tooling materials are transforming tablet compression to boost quality and cut operational costs in pharmaceutical production.

Cleanroom systems are purposely designed to simplify the implementation of the aseptic manufacturing space that the industry needs to meet future sterile injectable capacity demand.

By adopting these best practices, biotech sponsors can foster more transparent, efficient, and productive collaborations with their CDMO partners.

Using QRM gives a company the ability to maintain compliance while also identifying product issues that could be harmful to the consumers, some being susceptible patients.

Explore how particle-engineered calcium carbonate offers a viable alternative to titanium dioxide in tablet coatings, achieving good opacity, process efficiency, and comparable tablet properties.

Innovations in drug delivery formats are enabling more patient-centric treatments and helping to boost patient compliance. Read more about the advances being developed to expand ODT technology.

Examine eight principles that show how to move beyond digital buzzwords and drive real business impact, as well as learn how one global leader is scaling transformation.

Sterile manufacturing relies on three main contamination control strategies (CCSs): cleanrooms, RABS, and isolators. Understand how each system compares in sterility assurance and startup cost.

This chapter of The Aqueous Cleaning Handbook explains what an aqueous cleaner is, what it contains, and how it can improve your cleaning process.

Find out how strategic U.S.-based manufacturing and supply chain diversification can reduce risk, lower costs, and enhance supply reliability for pharmaceutical products.

Gain valuable insight into the optimization and scalability of perfusion media and processes, driving progress in biotechnological processes for monoclonal antibody production.

Physiologically based pharmacokinetic (PBPK) modeling advancements are helping drug sponsors mitigate risk in preclinical and clinical studies through early identification of poor absorption properties.

The industry is shifting to cloud-based Manufacturing Execution Systems (MES). See how you can use a modern MES to enhance efficiency, collaboration, and compliance.

Drawing on our extensive expertise in sterile injectables, here, we highlight practical strategies and solutions to help navigate challenges and support the production of high-quality PFS therapies.

Learn to identify potential product failure points and design robust formulations and processes for lyophilized products backed by solid data.

Reveal how one pharmaceutical facility overcame strict cross-contamination rules and space limits without costly building modifications to ensure operational continuity.

Uncover how using mesoporous silica as a means to enhance the micronization process is redefining the path to more efficient and reliable API formulation.